Adult Volunteers Needed for Stanford Flu Vaccine Study
Posted on: Thursday, 22 June 2006, 15:00 CDT
In an effort to broaden the U.S. supply of influenza vaccine, researchers at the Stanford-Lucile Packard Children's Hospital Vaccine Program are seeking volunteers for a study that will evaluate a flu vaccine manufactured in Australia.
Stanford is one of eight U.S. sites participating in the vaccine trial.
Cornelia Dekker, MD, associate professor of pediatric infectious diseases and director of the Stanford-Packard vaccine program, said the study is important to the development of an adequate supply of vaccine for upcoming flu seasons.
Inactivated influenza virus vaccines have been available in the United States for more than 50 years. However, in 2004, nearly half of the normal supply of seasonal influenza vaccine was unavailable when one of two manufacturers of FDA-licensed flu vaccine had to withdraw its product because of safety concerns.
This event highlighted the need for a greater number of vaccine manufacturers to ensure more secure supplies, Dekker said.
For the study, researchers are recruiting individuals ages 18 to 64 who are in good health, who are not allergic to eggs and who have not experienced severe reactions to a flu vaccine in the past.
Participants will be injected with one of four formulations of a standard dose of flu vaccine or a placebo. Volunteers will make three study-related visits during a period of three to four weeks, and will be reimbursed $30 for each completed visit.
The Australian vaccine is manufactured by CSL Limited, which has been making influenza vaccines for almost 40 years. The study is sponsored by the National Institute of Allergy and Infectious Diseases.
For more information, call the Stanford-Packard Vaccine Program at (650) 498-7284 or visit the Web site at http://vaccines.stanford.edu.
Stanford University Medical Center integrates research, medical education and patient care at its three institutions -- Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu.
Source: Business Wire
Related Articles
- Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
- Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu
- Vical Begins Trial of DNA Vaccine for Bird Flu
- MedImmune and National Institutes of Health Begin Clinical Testing of a Live, Attenuated Intranasal Vaccine Against an H5N1 Avian Influenza Virus
- Merck to Create New Patient Assistance Program for Vaccines
- Stanford Study of Mail-Based Arthritis-Care Program Seeks Volunteers
- China to Fast-Track Approval of Human Vaccines for Bird Flu
- Thai Gov't to Vaccinate 150,000 Workers Against Influenza
- NZ Prepared to Vaccinate Against Bird Flu
- Pneumonia Vaccine Protects Against Flu Complications
User Comments (0)

RSS Feeds